Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

116 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Diagnostic Value of JC Polyomavirus Viruria, Viremia, Serostatus and microRNA Expression in Multiple Sclerosis Patients Undergoing Immunosuppressive Treatment.
Prezioso C, Ciotti M, Brazzini G, Piacentini F, Passerini S, Grimaldi A, Landi D, Nicoletti CG, Zingaropoli MA, Iannetta M, Altieri M, Conte A, Limongi D, Marfia GA, Ciardi MR, Mastroianni CM, Palamara AT, Moens U, Pietropaolo V. Prezioso C, et al. Among authors: ciardi mr. J Clin Med. 2022 Jan 11;11(2):347. doi: 10.3390/jcm11020347. J Clin Med. 2022. PMID: 35054041 Free PMC article.
Human polyomavirus JC replication and non-coding control region analysis in multiple sclerosis patients under natalizumab treatment.
Pietropaolo V, Bellizzi A, Anzivino E, Iannetta M, Zingaropoli MA, Rodio DM, Morreale M, Pontecorvo S, Francia A, Vullo V, Palamara AT, Ciardi MR. Pietropaolo V, et al. Among authors: ciardi mr. J Neurovirol. 2015 Dec;21(6):653-65. doi: 10.1007/s13365-015-0338-y. Epub 2015 May 1. J Neurovirol. 2015. PMID: 25930159 Free PMC article.
Natalizumab Affects T-Cell Phenotype in Multiple Sclerosis: Implications for JCV Reactivation.
Iannetta M, Zingaropoli MA, Bellizzi A, Morreale M, Pontecorvo S, D'Abramo A, Oliva A, Anzivino E, Lo Menzo S, D'Agostino C, Mastroianni CM, Millefiorini E, Pietropaolo V, Francia A, Vullo V, Ciardi MR. Iannetta M, et al. Among authors: ciardi mr. PLoS One. 2016 Aug 3;11(8):e0160277. doi: 10.1371/journal.pone.0160277. eCollection 2016. PLoS One. 2016. PMID: 27486658 Free PMC article. Clinical Trial.
Dynamic changes of MMP-9 plasma levels correlate with JCV reactivation and immune activation in natalizumab-treated multiple sclerosis patients.
Iannetta M, Zingaropoli MA, Latronico T, Pati I, Pontecorvo S, Prezioso C, Pietropaolo V, Cortese A, Frontoni M, D'Agostino C, Francia A, Vullo V, Mastroianni CM, Liuzzi GM, Ciardi MR. Iannetta M, et al. Among authors: ciardi mr. Sci Rep. 2019 Jan 22;9(1):311. doi: 10.1038/s41598-018-36535-5. Sci Rep. 2019. PMID: 30670793 Free PMC article.
Infectious risk in multiple sclerosis patients treated with disease-modifying therapies: A three-year observational cohort study.
Zingaropoli MA, Pasculli P, Iannetta M, Perri V, Tartaglia M, Crisafulli SG, Merluzzo C, Baione V, Mazzochi L, Taglietti A, Pauri F, Frontoni M, Altieri M, Gaeta A, Antonelli G, Conte A, Mastroianni CM, Ciardi MR. Zingaropoli MA, et al. Among authors: ciardi mr. Mult Scler J Exp Transl Clin. 2022 Jan 4;8(1):20552173211065731. doi: 10.1177/20552173211065731. eCollection 2022 Jan-Mar. Mult Scler J Exp Transl Clin. 2022. PMID: 35003758 Free PMC article.
B- and T-Cell Responses After SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis Receiving Disease Modifying Therapies: Immunological Patterns and Clinical Implications.
Iannetta M, Landi D, Cola G, Campogiani L, Malagnino V, Teti E, Coppola L, Di Lorenzo A, Fraboni D, Buccisano F, Grelli S, Mozzani M, Zingaropoli MA, Ciardi MR, Nisini R, Bernardini S, Andreoni M, Marfia GA, Sarmati L. Iannetta M, et al. Among authors: ciardi mr. Front Immunol. 2022 Jan 17;12:796482. doi: 10.3389/fimmu.2021.796482. eCollection 2021. Front Immunol. 2022. PMID: 35111162 Free PMC article. Clinical Trial.
Higher Levels of Osteoprotegerin and Immune Activation/Immunosenescence Markers Are Correlated with Concomitant Bone and Endovascular Damage in HIV-Suppressed Patients.
D'Abramo A, Zingaropoli MA, Oliva A, D'Agostino C, Al Moghazi S, De Luca G, Iannetta M, d'Ettorre G, Ciardi MR, Mastroianni CM, Vullo V. D'Abramo A, et al. Among authors: ciardi mr. PLoS One. 2016 Feb 25;11(2):e0149601. doi: 10.1371/journal.pone.0149601. eCollection 2016. PLoS One. 2016. PMID: 26913505 Free PMC article.
116 results